Published in PLoS One on January 29, 2016
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
HPV screening for cervical cancer in rural India. N Engl J Med (2009) 14.13
Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer (1999) 8.61
Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta (1996) 7.79
Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet (2007) 6.77
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol (2009) 4.99
Large loop excision of the transformation zone (LLETZ). A new method of management for women with cervical intraepithelial neoplasia. Br J Obstet Gynaecol (1989) 3.27
Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy. Clin Infect Dis (2008) 1.91
Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst (2003) 1.84
Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity. AIDS (2012) 1.50
Anti-HIV drugs for cancer therapeutics: back to the future? Lancet Oncol (2009) 1.49
Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer (2003) 1.43
Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection. Int J Gynaecol Obstet (1999) 1.27
Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev (2000) 1.19
Repositioning HIV protease inhibitors as cancer therapeutics. Curr Opin HIV AIDS (2008) 1.12
Therapy of human papillomavirus-related disease. Vaccine (2012) 1.11
Management of cervical premalignant lesions. Best Pract Res Clin Obstet Gynaecol (2005) 1.10
Analytical performance of the Investigational Use Only Cervista HPV HR test as determined by a multi-center study. J Clin Virol (2009) 1.01
The efficacy of 9-cis-retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: results of a randomized double-blind clinical trial. Cancer Epidemiol Biomarkers Prev (2003) 0.99
Interlaboratory variation in the performance of liquid-based cytology: insights from the ATHENA trial. Int J Cancer (2013) 0.99
HIV Infection Alters the Spectrum of HPV Subtypes Found in Cervical Smears and Carcinomas from Kenyan Women. Open Virol J (2013) 0.99
Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study. Gynecol Oncol (2009) 0.92
Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro. Antivir Ther (2006) 0.91
Papanicolaou smears and cervical inflammatory cytokine responses. J Inflamm (Lond) (2007) 0.89
Safety and efficacy of lopinavir/ritonavir during pregnancy: a systematic review. AIDS Rev (2013) 0.88
Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia. Taiwan J Obstet Gynecol (2012) 0.84
Efficacy and safety of photodynamic therapy for cervical intraepithelial neoplasia: a systemic review. Photodiagnosis Photodyn Ther (2014) 0.84
Established and potential strategies against papillomavirus infections. J Antimicrob Chemother (2004) 0.83
Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS/MS technology. J Pharm Biomed Anal (2013) 0.83
Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm. Taiwan J Obstet Gynecol (2013) 0.82
Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells. Antivir Ther (2011) 0.79
Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2: a randomized controlled trial. Am J Obstet Gynecol (2013) 0.77
Oral Lopinavir Use and Human Papillomavirus Infection in HIV-Positive Women. J Acquir Immune Defic Syndr (2015) 0.77